Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity

Next Previous
Search
Trial Profile

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 11 Mar 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 03 Mar 2023 Status changed from active, no longer recruiting to completed.
  • 04 Nov 2022 Results assessing effectiveness of naltrexone+bupropion medication and behavioral weight loss therapy alone and combined for Binge-eating disorder comorbid with obesity presented at The Obesity Society: ObesityWeek 2022
  • 26 Oct 2022 Results assessing the effectiveness of naltrexone-bupropion and behavioral weight loss therapy, alone and combined, for binge-eating disorder comorbid with obesity published in the American Journal of Psychiatry

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top